The AI-based program AlphaFold predicts a protein's 3D structure with remarkable accuracy. However, it tends to reduce heterogeneous structures to a single dominant conformation, or shape, and ...
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
The MASAI trial1 concludes that artificial intelligence (AI)-supported screening “can efficiently improve screening performance” and “may be considered for implementation in clinical practice”.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results